About Tangdu Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Tang-Du Hospital
26
Nanfang Hospital of Southern Medical University
6
Xijing Hospital
5
Peking University Third Hospital
4
Chongqing Jiachen Biotechnology Ltd.
3
Peking University First Hospital
3
Zai Lab (Shanghai) Co., Ltd.
3
Air Force Military Medical University, China
2
Capital Medical University
2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2
Chinese PLA General Hospital
2
Clinical Trials at Tangdu Hospital
During the past decade, Tangdu Hospital conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 4 clinical trials were completed, i.e. on
average, 5.6% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
2009-04-01
2013-05-01
Completed
360
BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
2010-04-19
2017-11-26
Completed
364
Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients
2010-06-01
2014-01-01
Completed
378
Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China
2012-10-01
2015-10-01
Unknown status
400
Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease
2012-11-01
2015-03-01
Completed
14,032
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tangdu Hospital" #1 sponsor was "Tang-Du Hospital" with 26 trials, followed by "Nanfang Hospital of Southern Medical University" with 6 trials
sponsored, "Xijing Hospital" with 5 trials sponsored, "Peking University Third Hospital" with 4 trials sponsored and "Chongqing Jiachen Biotechnology Ltd."
with 4 trials sponsored. Other sponsors include 46 different institutions and
companies that sponsored additional 43 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tangdu Hospital"
#1 collaborator was "Tang-Du Hospital" with 14 trials as a collaborator, "LinkDoc Technology (Beijing) Co. Ltd." with 8 trials as a collaborator, "First Affiliated Hospital Xi'an Jiaotong University" with 6 trials as a collaborator, "Changhai Hospital" with 5 trials as a collaborator and "China Meitan General Hospital" with 5 trials as a collaborator. Other collaborators include 355 different institutions and companies that were
collaborators in the rest 214 trials.
Clinical Trials Conditions at Tangdu Hospital
According to Clinical.Site data, the most researched conditions in "Tangdu Hospital" are
"Hepatitis B, Chronic" (6 trials), "Non-small Cell Lung Cancer" (6 trials), "Chronic Hepatitis B" (5 trials), "Fertilization" (4 trials) and "Acute Stroke" (2 trials). Many other conditions were trialed in "Tangdu Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Tangdu Hospital
Most popular intervention types in "Tangdu Hospital" are "Drug" (46 trials), "Procedure" (18 trials), "Device" (13 trials), "Other" (12 trials) and "Behavioral" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Surgeries" (7 trials), "Sevoflurane" (4 trials), "Propofol" (3 trials) and "DAG181" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Tangdu Hospital
The vast majority of trials in "Tangdu Hospital" are
86 trials for "All" genders and 9 trials for "Female" genders.
Clinical Trials Status at Tangdu Hospital
Currently, there are NaN active trials in "Tangdu Hospital".
undefined are not yet recruiting,
13 are recruiting,
7 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 33 completed trials in Tangdu Hospital,
1 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Tangdu Hospital, 3 "Phase 1"
clinical trials were conducted, 20 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 9 trials, and there were
also 27 trials that are defined as “Not Applicable".